Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial
Dodel, Richard, Prof, Rominger, Axel, MD, Bartenstein, Peter, MD, Barkhof, Frederik, MD, Blennow, Kaj, PhD, Förster, Stefan, MD, Winter, Yaroslav, MD, Bach, Jan-Philipp, MD, Popp, Julius, MD, Alferink, Judith, MD, Wiltfang, Jens, MD, Buerger, Katharina, MD, Otto, Markus, MD, Antuono, Piero, MD, Jacoby, Michael, MD, Richter, Ralph, MD, Stevens, James, MD, Melamed, Isaac, MD, Goldstein, Jerome, MD, Haag, Stefan, MD, Wietek, Stefan, PhD, Farlow, Martin, MD, Jessen, Frank, MD
Published in Lancet neurology (01.03.2013)
Published in Lancet neurology (01.03.2013)
Get full text
Journal Article